Optical coherence tomography firm Imalux of Cleveland announced the closing of an offering of preferred shares.
The offering generated proceeds of $5.1 million, including $2.5 million in bridge financing. Imalux investors include Early Stage Partners, ElectroSonics Medical, Reservoir Venture Partners, and Symark.
Imalux plans to use the new funding to pursue clinical validation of its Niris optical coherence technology (OCT) system. Part of the funding will be used to support multicenter studies under way on use of the product for bladder cancer applications.
By AuntMinnie.com staff writers
September 27, 2007
Related Reading
Imalux nets $4.8 million in refinancing, January 1, 2005
Imalux Niris gets FDA nod, January 5, 2005
Imalux collects $3.5 million in refinancing, September 24, 2003
Copyright © 2007 AuntMinnie.com
